Journal of Acute Care

Register      Login

VOLUME 1 , ISSUE 3 ( September-December, 2022 ) > List of Articles

Original Article

Appropriateness of Antibiotics in Sepsis Patients at a Tertiary Referral ICU

Keywords : Empirical antibiotic, ICU mortality, 28-day mortality, ICU length of stay, Antibiotic resistance

Citation Information : Appropriateness of Antibiotics in Sepsis Patients at a Tertiary Referral ICU. 2022; 1 (3):124-127.

DOI: 10.5005/jp-journals-10089-0057

License: CC BY-NC 4.0

Published Online: 03-05-2023

Copyright Statement:  Copyright © 2022; The Author(s).


Background: Sepsis is a life-threatening condition that requires the early use of appropriate empirical antibiotics. However, sepsis outcomes are often complicated by the increased incidence of antibiotic resistance, which is attributed to the use of inappropriate antibiotics. Antibiotics are termed inappropriate when the suspected pathogen is resistant to the drug administered or when there is a delay in administration. Materials and methods: This is a prospective observational study that aims to compare the impact of appropriate antimicrobial therapy (AAT) and inappropriate antimicrobial therapy (IAAT) on the outcome of sepsis or septic shock cases in the intensive care unit (ICU). Primary outcome measures included ICU mortality and 28-day mortality, and secondary outcome measures, vasopressor free days (VFD), hemodialysis free days (HFD), ventilator free days, ICU length of stay (LOS), and oxygen requirement days. Results: Out of 100 patients included in the study, 49 patients received AAT and had a lower ICU mortality compared to the 51 patients who received IAAT (10 vs 31%, p = 0.009) and also 28-day mortality (14 vs 37%, p = 0.009). ICU LOS was also shorter in those receiving AAT. Conclusion: The use of appropriate and timely antibiotics can lead to decreased mortality and morbidity in patients with sepsis. This requires an understanding of the prevailing local microbiological flora and the local antibiograms and the use of standardized protocols.

  1. Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 2021;47(11):1181–1247. DOI: 10.1007/s00134-021-06506-y
  2. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) study. EPIC International Advisory Committee. JAMA 1995;274(8):639–644.
  3. Davey PG, Marwick C. Appropriate vs. inappropriate antimicrobial therapy. Clin Microbiol Infect 2008;14(Suppl 3):15–21. DOI: 10.1111/j.1469-0691.2008.01959.x
  4. Brusselaers N, Labeau S, Vogelaers D, et al. Value of lower respiratory tract surveillance cultures to predict bacterial pathogens in ventilator-associated pneumonia: systematic review and diagnostic test accuracy meta-analysis. Intensive Care Med 2013;39(3):365–375. DOI: 10.1007/s00134-012-2759-x
  5. Marquet K, Liesenborgs A, Bergs J, et al. Incidence and outcome of inappropriate in-hospital empiric antibiotics for severe infection: a systematic review and meta-analysis. Crit Care 2015;19(1):63. DOI: 10.1186/s13054-015-0795-y
  6. Kang CI, Kim SH, Park WB, et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005;49(2):760–766. DOI: 10.1128/AAC.49.2.760-766.2005
  7. Sinha M, Jupe J, Mack H, et al. Emerging technologies for molecular diagnosis of sepsis. Clin Microbiol Rev 2018;31(2):e00089-17. DOI: 10.1128/CMR.00089-17
  8. Shorr AF, Micek ST, Welch EC, et al. Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay. Crit Care Med 2011;39(1):46–51. DOI: 10.1097/CCM.0b013e3181fa41a7
  9. Kioka MJ, DiGiovine B, Rezik M, et al. Anaerobic antibiotic usage for pneumonia in the medical intensive care unit. Respirology 2017;22(8):1656–1661. DOI: 10.1111/resp.13111
  10. Lellouche F, Simon M, L’Her E. Oxygen therapy in suspected acute myocardial infarction. N Engl J Med 2018;378(2):201. DOI: 10.1056/NEJMc1714937
  11. Chu DK, Kim LH, Young PJ, et al. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and metaanalysis. Lancet 2018;391(10131):1693–1705. DOI: 10.1016/S0140-6736(18)30479-3
  12. Mackle D, Bellomo R, Bailey M, et al. Conservative oxygen therapy during mechanical ventilation in the ICU. N Engl J Med 2020;382(11):989–998. DOI: 10.1056/NEJMoa1903297
  13. O’Driscoll BR, Howard LS, Earis J, et al. British thoracic society guideline for oxygen use in adults in healthcare and emergency settings. BMJ Open Respir Res 2017;4(1):e000170. DOI: 10.1136/bmjresp-2016-000170
  14. Otero RM, Nguyen HB, Huang DT, et al. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest 2006;130(5):1579–1595. DOI: 10.1378/chest.130.5.1579
  15. Mira JC, Gentile LF, Mathias BJ, et al. Sepsis pathophysiology, chronic critical illness and persistent inflammation-immunosuppression and catabolism syndrome. Crit Care Med 2017;45(2):253–262. DOI: 10.1097/CCM.0000000000002074
  16. Mostel Z, Perl A, Marck M, et al. Post-sepsis syndrome–an evolving entity that afflicts survivors of sepsis. Mol Med 2020;26(1):6. DOI: 10.1186/s10020-019-0132-z
  17. Hui K, Nalder M, Buising K, et al. Patterns of use and appropriateness of antibiotics prescribed to patients receiving haemodialysis: an observational study. BMC Nephrol 2017;18(1):156. DOI: 10.1186/s12882-017-0575-9
  18. McGowan JE Jr. Economic impact of antimicrobial resistance. Emerg Infect Dis 2001;7(2):286–292. DOI: 10.3201/eid0702.010228
  19. Buchman TG, Simpson SQ, Sciarretta KL, et al. Sepsis among medicare beneficiaries: 1. The burdens of sepsis, 2012–2018. Crit Care Med 2020;48(3):276–288. DOI: 10.1097/CCM.0000000000004224
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.